Form 8-K - Current report:
SEC Accession No. 0001193125-24-250197
Filing Date
2024-11-04
Accepted
2024-11-04 06:06:33
Documents
17
Period of Report
2024-10-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d892646d8k.htm   iXBRL 8-K 76000
2 EX-10.1 d892646dex101.htm EX-10.1 237390
3 EX-10.2 d892646dex102.htm EX-10.2 68892
4 EX-10.3 d892646dex103.htm EX-10.3 91512
  Complete submission text file 0001193125-24-250197.txt   762239

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA acab-20241030.xsd EX-101.SCH 3130
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acab-20241030_def.xml EX-101.DEF 14012
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE acab-20241030_lab.xml EX-101.LAB 23271
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acab-20241030_pre.xml EX-101.PRE 14850
20 EXTRACTED XBRL INSTANCE DOCUMENT d892646d8k_htm.xml XML 7216
Mailing Address 6 ST JOHNS LANE, FLOOR 5 NEW YORK NY 10013
Business Address 6 ST JOHNS LANE, FLOOR 5 NEW YORK NY 10013 248-890-7200
Atlantic Coastal Acquisition Corp. II (Filer) CIK: 0001893219 (see all company filings)

EIN.: 871013956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41224 | Film No.: 241420580
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)